BTIG Maintains Buy on Medtronic, Raises Price Target to $109
Benzinga Newsdesk 3 days ago
Analyst RatingsNewsPrice TargetHot
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
BTIG analyst Ryan Zimmerman maintains Medtronic (NYSE:MDT) with a Buy and raises the price target from $99 to $109.
BTIG analyst Ryan Zimmerman maintains Medtronic (NYSE:MDT) with a Buy and raises the price target from $99 to $109.
